H ILAR T U MOURS INCLUDE CARCl-
n o m as o f the hepat ic du c t (Klatskin's tumour) (1) , gallbladder carcin oma and metastases located in the conflue nce. A tumour is type l when stri cture is limited to the commo n hepatic duct, type II when both left and right hepa tic duc ts are involved, and type Ill when on e or more sectorial ducts are involved (Figure l ).
T h e an atomical variations of the bile duc ts around the conflue nce have been described byCou inaud (2) ( Figure  2 ) . T hey are importan t fo r precise diagnosis of the sec tors or segments involved, but also for ma nagement. These variations are more difficult to recognize whe n the ducts are e nlarged above the confluence.
Bifurcation tumours a re extreme ly diffic ult to manage surgically. Extensive resect ion to cure the disease is certa in ly the best treatment when possible (3), as is liver transpla ntat ion, which can on ly be proposed for carefu lly selected young patients with invasive carcinoma of the bifurcatio n wi th o ut ex rra h epa ti c sprea<l.
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Figure 1) T ypes of hilar strictures (bismuth)
Palliative surgery, whic h is the usual outcome of laparotomy ( 4) and which is not easy no r comple te ly successful, has a mortality rate between lO an<l 15%. Moreover, when the pat ient survives after operation , the mean survival rime is very short: between six and 16 months (5,6).
Finall y, o n ly a small minorit y of Hopital Erasme -Universire Libre de Bruxelles, Brussels, Belgium Con·espondence and reprints: Dr M Cremer , Hofiital Erasme -Universite Libre de Bruxelles , Brussels , Belgium patients hav ing a tumo ur of t he confluen ce a re can<lidates for surgery because of associa t ed diseases often related to ageing, hut also to ex tension of the tumour and th e prese nce of lymph nodes.
The pe rcutaneous-transhepat ic approach to bifurcation tumours carries a high rate of severe complicat ions, cg, peritoneal bile leakage, h emobil ia anJ cholangitis, and fa il ure to <lrain these leaves the patie nt even worse (7 ,8 ) .
A lthough endoscopic scenting has Bifurcation tumours no longer wamng tM chnlangiti~ to occur in the undrained lobe. The most frequencly used stenr for the hdar tumours in the authors' serae~ is still the black 'sigmoid C shaped' polyamide endoprosthcsis (Guerbet-Biocrol, Paris, France) wirh an internal diameter of2.6 mm, an effective length of 11 cm, and a proximal bend adapted to the an~11omy of the intrahepatiL ducts. Unlike the straight Amsterdam slent which docs not conform to the anatomical angulation of lhe left heratic duct al the confluence, the hilar Biotrol scent has an angulation at the proximal end designed specifically for use in hilar strictures, prcvcnung dislocation from the left hepatic duct. The distal C shaped end prevents duodenal perforntion, reported in rare instances with the straight Stent. The lefr hepatic duct must be stenred first for patients with type II or lll strictures as access to the right is nearly always easier for anatomical reasons.
In one patient of four w1rh type 11 and Ill strictures 1t 1s necessary to follow the percutaneous route LO lhread a guidewire through a stricture that cannot be reached by a trampapillary approach. An externa l-internal Ring catheter is left in place beside the first endoscopic scent. Two days lacer, a second stenc is irn,encd using the 'rendezvous' trnnspapillary technique, alongside the percutaneous guidewire. Th is approach has reduced sepsis and 30 day mortality, resulting in longer survival rates (Table I) .
Furthermore, the authors observed that the lowest rate of late dealh from sepsis or jaundice occurred in the group of patients with the most invasive tumours ( type ll and Ill) chat were completely treated. The rate of late death was paradoxically lower than in the group with rype I strictures. l I igher rates were seen in patients with incomplete drainage ( Table 2) .
Late complications of endoscopic internal biliary drainage for the 59 patients who survived more than one month were mostly related to clogging of the scent (27<l{i), with a mean slent survival time of 4.8 months. Dislocation (8%) and breakage of the scenr (2%) were observed initially with straight AmsterJam srents hue nor with the benJ-type Stent, which hetter fits the left he patic Jucr. C holecystitis was observed in 34 pauents.
The results using this type of active management of hilar tumours are as good as those ohtaineJ for palliative treatment of pancreatic cancer (Tahle 3).
The present anJ the future are con-cemeJ with the self-expanJing metallic scents (18, 24 and 30 French), for which little endoscopic experience has heen obtained s in ce the work of the European Multiccntric S tudy Group in May 1989 (104 pauencs). Technical problems for type II and III hilar stric, cures remain, for which scents must be inserteJ simultaneous ly on hoth sides of the confluence.
Percurnncous transhepauc. manage, ment with these 'wallstents' has shown secondary involvement of the scent by the tumour, but up to now few patients have been createJ with two wallsrents, and only by th e preventative percutaneous approach. CONCLUSION Endoscopic and combineJ pe rcutaneous-endoscopic transpapi llary srenting with multiple large e ndoproscheses has a high technical success race (97%), a nd is a palliative method of Percutaneous drainage of type II and Ill tumours has a higher mortality rnrc (30%) and a lowe r mean length of survival (two co four mnnths).
The main rule to be followeJ 1s drainage of horh lobes of the liver immediately following ERCP, using the rendezvous technique only after failure to threaJ a gu1dewire through one of the strictures.
Additional therapy such as radiotherapy anJ chemotherapy have not
